MoVE Trial: Motivational Strategies to Empower African Americans to Improve Dialysis Adherence
- Conditions
- End Stage Renal Disease on Dialysis
- Interventions
- Behavioral: Motivational interviewing
- Registration Number
- NCT05735743
- Lead Sponsor
- Vanderbilt University Medical Center
- Brief Summary
MoVE Trial is a randomized clinical trial designed to rigorously test the impact of a behavioral intervention (culturally tailored motivational interviewing - (MOVE)) delivered by trained health coaches, on hemodialysis treatment non-adherence. It is a a two-arm, parallel group randomized clinical trial with 24-week follow-up. It involves completion of surveys by patients enrolled in the study. It also involves participation in motivational interviewing sessions by patients who are randomized to the intervention (MI).
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 176
- African American
- Receiving hemodialysis treatments
- Been on hemodialysis for more than 30 days
- 18 years of age and older
- Within a 2-month look back at the time of screening, patients who have missed at least one dialysis session or shortened at least one dialysis session by 15 minutes.
- Not self-identified as African American
- Impaired with mental status or severe illness
- Non-English speaking
- No documented evidence of dialysis treatment non-adherence
- Missed or shortened treatments due to hospitalizations or excused travel
- Terminal condition
- Living in a nursing home/rehab
- Planned transplant within the next 6 months
- Planned conversion to peritoneal dialysis within the next 6 months
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Participants receiving intervention Motivational interviewing Motivational interviewing intervention
- Primary Outcome Measures
Name Time Method Dialysis treatment adherence Baseline to 24 weeks post-intervention Abstraction of dialysis treatment adherence data from the dialysis units' records which includes data on every treatment that occurred or should have occurred within the time frame. Records will reflect dialysis treatments which were completed, shortened, missed or did not occur due to hospitalizations, ER visits or travel.
- Secondary Outcome Measures
Name Time Method Change in Autonomy Support Baseline, Week 8, Week 24 Change in autonomy support will be measured by the 6-item Health Care Climate (HCC) questionnaire. Questions range in score from 1 to 7, and overall score is a mean of all items (range 1 - 7). Lower scores reflect less autonomous support, and higher scores reflect greater autonomous support.
Change in Autonomous Regulation Baseline, Week 8, Week 24 Change in autonomous regulation will be measured by the 6-item Autonomous Regulation (AR) questionnaire. Questions range in score from 1 to 7, and overall score is a mean of all items (range 1 - 7). Lower scores reflect less autonomous regulation, and higher scores reflect greater autonomous regulation
Change in Perceived competence Baseline, Week 8, Week 24 Change in perceived competence will be measured by the 8-item Perceived Kidney Disease Self-Management Scale (PKDSMS) questionnaire.Each question ranges in score from 1 to 5. Four of the items (#s 1, 2, 6, 7) are reversed-scored. The score is the sum of the 8 individual items. The total PKDSMS score can range from 8 to 40, with higher scores indicating more confidence in self-managing one's (dialysis).
Change in Optimism Baseline, Week 8, Week 24 Change in optimism will be measured by the 10-item Life Orientation Test - Revised (LOT-R) questionnaire which assesses individual differences in generalized optimism versus pessimism. Only 6 of the 10 items on the revised LOT are used to derive an optimism score. Four of the items are filler items and are not used in scoring. Of the 6 survey questions utilized, each question ranges in score from 1 to 5. Thus, scores in principle can range from 6 to 30.
Change in Apathy Baseline, Week 8, Week 24 Change in apathy will be measured by the 7-item Apathy Evaluation Scale survey (AES-S) which measures three domains of apathy: deficits in goal-directed behavior; a decrement in goal-related thought content; and emotional indifference with flat affect. Each question ranges in score from 1 to 4. Item 3 is reverse-scored and then the sum of the 7 item scores is calculated. Range of scores is 7-28.
Trial Locations
- Locations (6)
DaVita Philadelphia PMC Dialysis
🇺🇸Philadelphia, Pennsylvania, United States
DaVita University City Dialysis
🇺🇸Philadelphia, Pennsylvania, United States
Dialysis Clinic, Inc.
🇺🇸Nashville, Tennessee, United States
Buttonwood DaVita Dialysis 449 N Broad St,
🇺🇸Philadelphia, PA 19123, Pennsylvania, United States
Vanderbilt Dialysis Clinic
🇺🇸Nashville, Tennessee, United States
Vanderbilt Dialysis Clinic East
🇺🇸Nashville, Tennessee, United States